Marshall Wace, LLP Macrogenics Inc Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Macrogenics Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 381,516 shares of MGNX stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

381,516

Previous 658,007 42.02%

Holding current value

$1.24 Million

Previous $2.8 Million 55.11%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.0 - $5.55 $829,473 - $1.53 Million	-276,491 Reduced 42.02%	381,516 $1.26 Million
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $2.06 Million - $11.5 Million	621,232 Added 1689.28%	658,007 $2.8 Million
Q1 2024 May 15, 2024	BUY	$9.77 - $21.47 $359,291 - $789,559	36,775 New	36,775 $541,000
Q2 2023 Aug 14, 2023	SELL	$4.62 - $7.54 $795,189 - $1.3 Million	-172,119 Reduced 66.73%	85,829 $459,000
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $1.24 Million - $1.87 Million	257,948 New	257,948 $1.85 Million
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $1.37 Million - $2.38 Million	-456,645 Reduced 65.71%	238,299 $824,000
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $1.56 Million - $6.94 Million	694,944 New	694,944 $2.05 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $319,011 - $438,715	-20,051 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $395,806 - $575,463	20,051 New	20,051 $420,000
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $723,955 - $1.27 Million	-38,123 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$19.41 - $26.0 $739,967 - $991,198	38,123 New	38,123 $871,000
Q2 2020 Aug 13, 2020	SELL	$5.2 - $29.12 $330,075 - $1.85 Million	-63,476 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.28 - $12.11 $271,677 - $768,694	63,476 New	63,476 $369,000
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $64,859 - $88,103	-4,470 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$11.11 - $25.6 $49,661 - $114,432	4,470 New	4,470 $80,000
Q4 2018 Feb 14, 2019	SELL	$11.75 - $21.42 $254,540 - $464,021	-21,663 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$19.26 - $23.46 $417,229 - $508,213	21,663 New	21,663 $464,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Macrogenics Inc Transaction History